Moreover, several lncRNAs, such as PCA3 and MALAT-1, can be used as diagnostic urinary biomarkers for prostate cancer [35–36], thus DANCR expression in the urine of prostate cancer patients should be measured and analyzed in the future. The gene discussed is PCA3; the disease is prostate carcinoma.